DVA Stock Recent News
DVA LATEST HEADLINES
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poised to gain.
The latest trading day saw DaVita HealthCare (DVA) settling at $162.36, representing a +0.22% change from its previous close.
DENVER , Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the healthcare system.
LOS ANGELES , Jan. 9, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California. DaVita's emergency response plan includes: Accounting for patients and teammates (employees), assessing facilities in the affected areas and identifying safe shelters.
DaVita HealthCare (DVA) closed the most recent trading day at $152.69, moving +0.77% from the previous trading session.
The latest trading day saw DaVita HealthCare (DVA) settling at $151.53, representing a -0.84% change from its previous close.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $155.06, denoting a +1.33% change from the preceding trading day.
Warren Buffett is recognized for his legendary ability to uncover high-quality and undervalued companies to invest in. Under his leadership, Berkshire Hathaway (BRK.B 0.86%) (BRK.A 1.37%) has crushed the returns of stock market benchmarks like the S&P 500 index.
Strength in kidney care services and expansion into international markets raise optimism for DVA stock.